Phase I/II Study to Assess the Safety, Pharmacokinetics (PK) and Efficacy of Lorvotuzumab Mertansine (LM, IMGN901) in Combination with Carboplatin/Etoposide in Patients with Solid Tumors Including Small-Cell Lung Cancer (SCLC)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 23; p. ix498
Main Authors Spigel, D.R., Bendell, J., Mita, A.C., Argiris, A., Kurkjian, C., Hann, C.L., Segota, Z., Guild, R., Mastico, R., Guiterrez, M.E.
Format Journal Article
LanguageEnglish
Published 01.09.2012
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/S0923-7534(20)34089-8